Monoclonal antibodies for the treatment of multiple myeloma An overview of the development and use of monoclonal antibodies in the treatment of patients with multiple myeloma.…
Community pharmacies incentivised to refer frequent users of reliever inhalers to general practice The new referral incentive will be part of the Pharmacy Quality Scheme for 2022/2023.…
Herbal medicines in pregnancy Herbal medicines are commonly used by women during pregnancy. This article explains the potential health risks and uncertainties around their use and how pharmacists can provide supporting information for women.…
Pharmacies to receive ‘fairer access’ to medicine margin under reimbursement reforms, say negotiators The new discount deduction scale will use separate discount rates for branded drugs, generics and appliances.…
Immune-related cancer toxicities: what pharmacists need to know In this episode of The PJ Pod, we explore the side effects of cancer immunotherapy and consider what pharmacists can do to support patients throughout the course of their treatment.… Supported content
NHS Scotland announces plan to switch patients to greener inhalers A strategy document, published by NHS Scotland, says that improvements in the way asthma and chronic obstructive pulmonary disease are managed could help reduce metered dose inhaler use.…
UK government rules out purchase of Evusheld over lack of data A spokesperson from the UK government has said it will "continue to explore the market for promising treatments that could prevent infection".…
Advanced therapy medicinal products: a comprehensive overview for pharmacy professionals An overview of the clinical, institutional, regulatory, safety and economic considerations of advanced therapy medicinal products.…
Best practice principles for inhaler prescribing How to select appropriate inhaler devices that balance the need to personalise treatment and optimise disease control while reducing the environmental impact of prescribing.…
Rates of hospital admissions for adverse drug reactions on the rise, research suggests The cost of hospital admissions for adverse drug reactions over the one-month period amounted to more than £490,000.…